Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2018.00512/full |
_version_ | 1818113138864685056 |
---|---|
author | Jaydeep Bhat Léonce Kouakanou Christian Peters Zhinan Yin Dieter Kabelitz |
author_facet | Jaydeep Bhat Léonce Kouakanou Christian Peters Zhinan Yin Dieter Kabelitz |
author_sort | Jaydeep Bhat |
collection | DOAJ |
first_indexed | 2024-12-11T03:30:04Z |
format | Article |
id | doaj.art-1e7112c05d814756a1c87538cc9c87c1 |
institution | Directory Open Access Journal |
issn | 1664-3224 |
language | English |
last_indexed | 2024-12-11T03:30:04Z |
publishDate | 2018-03-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj.art-1e7112c05d814756a1c87538cc9c87c12022-12-22T01:22:24ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-03-01910.3389/fimmu.2018.00512355599Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?Jaydeep Bhat0Léonce Kouakanou1Christian Peters2Zhinan Yin3Dieter Kabelitz4Institute of Immunology, University of Kiel, Kiel, GermanyInstitute of Immunology, University of Kiel, Kiel, GermanyInstitute of Immunology, University of Kiel, Kiel, GermanyThe First Affiliated Hospital, Biomedical Translational Research Institute, Guangdong Province Key Laboratory of Molecular Immunology and Antibody Engineering, Jinan University, Guangzhou, ChinaInstitute of Immunology, University of Kiel, Kiel, Germanyhttp://journal.frontiersin.org/article/10.3389/fimmu.2018.00512/fullBromodomain and ExtraTerminal domaincheckpoint inhibitorsDNA methylationgamma delta T cellshistone acetylationimmunotherapy |
spellingShingle | Jaydeep Bhat Léonce Kouakanou Christian Peters Zhinan Yin Dieter Kabelitz Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs? Frontiers in Immunology Bromodomain and ExtraTerminal domain checkpoint inhibitors DNA methylation gamma delta T cells histone acetylation immunotherapy |
title | Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs? |
title_full | Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs? |
title_fullStr | Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs? |
title_full_unstemmed | Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs? |
title_short | Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs? |
title_sort | immunotherapy with human gamma delta t cells synergistic potential of epigenetic drugs |
topic | Bromodomain and ExtraTerminal domain checkpoint inhibitors DNA methylation gamma delta T cells histone acetylation immunotherapy |
url | http://journal.frontiersin.org/article/10.3389/fimmu.2018.00512/full |
work_keys_str_mv | AT jaydeepbhat immunotherapywithhumangammadeltatcellssynergisticpotentialofepigeneticdrugs AT leoncekouakanou immunotherapywithhumangammadeltatcellssynergisticpotentialofepigeneticdrugs AT christianpeters immunotherapywithhumangammadeltatcellssynergisticpotentialofepigeneticdrugs AT zhinanyin immunotherapywithhumangammadeltatcellssynergisticpotentialofepigeneticdrugs AT dieterkabelitz immunotherapywithhumangammadeltatcellssynergisticpotentialofepigeneticdrugs |